Holen Sie sich die Stockscreener-App
2.20
8.64%
0.175
Handel nachbörslich:
2.17
-0.03
-1.36%
Finanzdaten der Pds Biotechnology Corporation-Aktie (PDSB)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
2.97%
10.10
|
10.41 | 10.52 | 12.70 | 9.4224 |
| Interest Income/Expense |
0.00%
1.1747
|
1.1748 | 1.0689 | 0.9954 | 0.9668 |
| Operating Income/Loss |
2.97%
-10.10
|
-10.41 | -10.52 | -12.70 | -9.4224 |
| Income/Loss From Continuing Operations Before Tax |
2.70%
-10.60
|
-10.90 | -10.85 | -12.94 | -9.6599 |
| Income Tax Expense/Benefit, Current |
-
|
- | - | - | - |
| Income/Loss From Continuing Operations After Tax |
2.70%
-10.60
|
-10.90 | -10.85 | -11.53 | -9.6599 |
|
Net Income/Loss
|
2.70%
-10.60
|
-10.90 | -10.85 | -11.53 | -9.6599 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
14,615%
34.82
|
0.2366 | 30.91 | 30.80 | 30.43 |
| Diluted Average Shares |
14,615%
34.82
|
0.2366 | 30.91 | 30.80 | 30.43 |
| Basic Earnings Per Share |
14.29%
-0.30
|
-0.35 | -0.35 | -0.37 | -0.32 |
| Diluted Earnings Per Share |
14.29%
-0.30
|
-0.35 | -0.35 | -0.37 | -0.32 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.93%
3.55%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):